Health: Medicines Shortage Debate

Full Debate: Read Full Debate

Baroness Thornton

Main Page: Baroness Thornton (Labour - Life peer)

Health: Medicines Shortage

Baroness Thornton Excerpts
Tuesday 22nd January 2019

(5 years, 3 months ago)

Lords Chamber
Read Full debate Read Hansard Text
Asked by
Baroness Thornton Portrait Baroness Thornton
- Hansard - -

To ask Her Majesty’s Government what representations they have received from representatives of pharmaceutical companies about an increase in the shortage of common medicines.

Baroness Manzoor Portrait Baroness Manzoor (Con)
- Hansard - - - Excerpts

My Lords, the Department of Health and Social Care has well-established procedures to deal with medicine shortages. We work closely with relevant stakeholders, including pharmaceutical companies, to help ensure that risks to patients are minimised when they arise. Medicine shortages are an ongoing issue and we continue to introduce new strategies to help tackle this problem, including the recent introduction of a mandatory reporting requirement for industry to notify us of impending shortages.

Baroness Thornton Portrait Baroness Thornton (Lab)
- Hansard - -

I thank the Minister for her Answer. If Ash Soni, president of the Royal Pharmaceutical Society, says he says never seen so many common drugs—naproxen and even aspirin, for example—affected by shortages, the complacent response from the Government seems inappropriate. It appears there may be many reasons for the shortages, including the looming Brexit deadline. Would the Minister inform the House what the Government intend to do about the export licences that the Secretary of State grants for the parallel trading of drugs? If the pound drops—let us hope it does not do so, but it certainly is a possibility—it will create shortages and profiteering. What strategy do the Government intend to follow under those circumstances?

Baroness Manzoor Portrait Baroness Manzoor
- Hansard - - - Excerpts

My Lords, the production of medicines is complex and highly regulated, as the noble Baroness says, and materials and processes must meet rigorous safety and quality standards. Supply problems can arise for various reasons, such as manufacturing issues, problems with the raw ingredients, regulatory issues and batch failures. I assure the noble Baroness that the Government are doing everything in their power to ensure that contingency plans are in place to address exactly the kind of issue she has just raised.